Ava Lias-Booker - Mar 1, 2024 Form 4 Insider Report for Physicians Realty Trust (DOC)

Role
Director
Signature
/s/ Christopher M. Bartoli, as attorney-in-fact
Stock symbol
DOC
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/1/2024, 04:01 PM
Previous filing
Jan 2, 2024
Next filing
Apr 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DOC Common shares, $0.01 par value Options Exercise +3.36K +74.95% 7.84K Mar 1, 2024 Direct F1
transaction DOC Common shares, $0.01 par value Options Exercise +7.48K +95.41% 15.3K Mar 1, 2024 Direct F1
transaction DOC Common shares, $0.01 par value Disposed to Issuer -15.3K -100% 0 Mar 1, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DOC 2022 Restricted Share Unit Grant Options Exercise $0 -3.36K -100% $0.00* 0 Mar 1, 2024 Common shares, $0.01 par value 3.36K Direct F3
transaction DOC 2023 Restricted Share Unit Grant Options Exercise $0 -7.48K -100% $0.00* 0 Mar 1, 2024 Common shares, $0.01 par value 7.48K Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ava Lias-Booker is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of the Issuer's common shares. Represents vesting of the time-based restricted stock units on March 1, 2024 pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated October 29, 2023 among the Issuer, Physicians Realty L.P., Healthpeak Properties, Inc. ("Healthpeak"), DOC DR Holdco, LLC and DOC DR LLC. The Issuer merged with and into DOC DR Holdco, LLC on March 1, 2024.
F2 Represents securities disposed of pursuant to the terms of the the Merger Agreement and each issued and outstanding common shares of the Issuer, held by the reporting person was automatically converted into the right to receive 0.674 of a share of Healthpeak common stock, subject to any adjustment, without interest.
F3 On March 1, 2022, the Reporting Person was granted 6,720 restricted stock units, which vest in two equal installments on March 1, 2023 and March 1, 2024, subject to the terms of the grant. The grant vested on March 1, 2024 pursuant to the terms of the Merger Agreement.
F4 On March 1, 2023, the Reporting Person was granted 7,483 restricted stock units, which vest in two equal installments on March 1, 2024 and March 1, 2025, subject to the terms of the grant. The grant vested on March 1, 2024 pursuant to the terms of the Merger Agreement.